Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06691659 · ClinicalTrials.gov registry record
Next-Generation Photon-Counting CT Technology: Development and Clinical Evaluation
A clinical trial of Radiation Protection and Image Enhancement, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- 250
- Enrollment target
- 1
- Study location
NCT06691659: Recruiting study of Radiation Protection and Image Enhancement, sponsored by University of Pennsylvania.
NCT06691659 is a study of Radiation Protection and Image Enhancement that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 250 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06691659, a study of Radiation Protection and Image Enhancement, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
This project aims to develop and evaluate a next-generation photon-counting CT prototype, and assess whether next-generation photon-counting CT--which enables reduced radiation dose, high spatial resolution, and spectral imaging--would facilitate improved diagnostic performance for abdominal, cardiothoracic, musculoskeletal, and neuroimaging.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST CT-DACE
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Center for Advanced Computed Tomography Imaging Services (CACTIS) - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2024-11-19 |
| Est. Completion | 2026-11-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06691659
The ClinicalTrials.gov registry entry for NCT06691659 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Radiation Protection appearing as the primary indexed condition, and to 1 intervention - of which CT-DACE is the first listed.
NCT06691659 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06691659 about?
NCT06691659 is a clinical study titled "Next-Generation Photon-Counting CT Technology: Development and Clinical Evaluation". This project aims to develop and evaluate a next-generation photon-counting CT prototype, and assess whether next-generation photon-counting CT--which enables reduced radiation dose, high spatial resolution, and spectral imaging--would facilitate improved diagnostic performance for abdominal, cardio...
What is the current status of trial NCT06691659?
This trial is currently recruiting. The enrollment target is 250 participants. The study started on 2024-11-19. Estimated completion is 2026-11-30.
What conditions does trial NCT06691659 study?
This clinical trial studies the following conditions: Radiation Protection, Image Enhancement.
What interventions are being tested in trial NCT06691659?
The interventions under investigation include: CT-DACE (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06691659?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06691659 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Radiation Protection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.